Smith+Nephew has introduced its Allevyn Complete Care foam dressing, which aims to provide advanced wound management solutions and improve pressure injury prevention.
The product features advanced technologies and a five-layer construction. Its performance is backed by clinical evidence and scientific data.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The dressing combines several mode-of-action technologies that aim to minimise leakage, reduce the frequency of dressing changes, and protect vulnerable skin.
According to Smith+Nephew, minimising disruption through fewer dressing changes and supporting skin protection are crucial goals in wound management.
The company reports that the new dressing locks in more exudate than other foam dressings while keeping more than 99% of bacteria away from the wound bed. These features reportedly minimise leakage, allow for longer wear times for uninterrupted healing, and have the potential to release over 10% of nursing time.
Additionally, the dressing’s unbonded sliding layers absorb as much as 93% of mechanical energy, contributing to a reduction in pressure injury risk by more than 65%.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSmith+Nephew’s advanced wound management president Rohit Kashyap said: “Allevyn Complete Care is a true next-generation dressing that reflects our continued commitment to wound care innovation, delivering meaningful benefit where it matters most.
“Every dressing is designed for strong performance in both wound treatment and pressure injury prevention, helping patients get back to what they love, whilst reducing the costly and complex clinical burden.”
The product is available in five shapes and various sizes. Smith+Nephew will first offer Allevyn Complete Care Foam Dressing in the US before expanding to Europe and other international markets from this year.
Last month, Smith+Nephew signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.
The agreement is intended to broaden Smith+Nephew’s offerings for percutaneous pelvic fracture fixation procedures and to enhance its position in trauma care involving high-impact, high-frequency cases.
